Clinical trial
A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients
NCT00394953 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00394953 |
|---|---|
| Title | A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients |
| Official title | A Randomized, Controlled, Open Label, Multicenter, Parallel-group Study to Compare the Effect of Mircera With That of Darbepoetin Alfa, Administered Intravenously at Extended Dosing Intervals, for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Hemodialysis |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anemia |
| Intervention type | Drug |
| Interventions | Darbepoetin alfa, methoxy polyethylene glycol-epoetin beta [Mircera] |
| Enrollment | 490 |
| Start date | Dec 1, 2006 |
| Primary completion | Nov 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | Nov 2, 2006 |
| Last update posted | Jan 20, 2017 |
| Countries | Australia, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Italy, Netherlands, Portugal, Spain and 2 more |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: